All Stories

  1. Poor Performance of the Determine HIV-1/2 Ag/Ab Combo Fourth-Generation Rapid Test for Detection of Acute Infections in a National Household Survey in Swaziland
  2. Short Communication: HIV Incidence Among Vulnerable Populations in Honduras: Results from an Integrated Behavioral and Biological Survey Among Female Sex Workers, Men Who Have Sex with Men, and Garifuna in Honduras, 2006
  3. Development of a Novel Rapid HIV Test for Simultaneous Detection of Recent or Long-Term HIV Type 1 Infection Using a Single Testing Device
  4. “What Took You So Long?” The Impact of PEPFAR on the Expansion of HIV Testing and Counseling Services in Africa
  5. Strengthening national laboratory health systems in the Caribbean region
  6. Comparative evaluation of rapid tests, HIV specific peptide EIA and Western Blot test for diagnosis of HIV-2 and HIV 1&2 infection
  7. Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation Studies
  8. Early Diagnosis of HIV Infection in the Breastfed Infant
  9. Assessment of BED HIV-1 Incidence Assay in Seroconverter Cohorts: Effect of Individuals with Long-Term Infection and Importance of Stable Incidence
  10. Determination of Mean Recency Period for Estimation of HIV Type 1 Incidence with the BED-Capture EIA in Persons Infected with Diverse Subtypes
  11. Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras
  12. Evaluating the BED Capture Enzyme Immunoassay to Estimate HIV Incidence Among Adults in Three Countries in Sub-Saharan Africa
  13. Dried tube specimens: A simple and cost-effective method for preparation of HIV proficiency testing panels and quality control materials for use in resource-limited settings
  14. Development of Two Avidity-Based Assays to Detect Recent HIV Type 1 Seroconversion Using a Multisubtype gp41 Recombinant Protein
  15. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review
  16. Current HIV‐2 diagnostic strategy overestimates HIV‐2 prevalence in China
  17. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay
  18. Mucosal HIV‐Binding Antibody and Neutralizing Activity in High‐Risk HIV‐Uninfected Female Participants in a Trial of HIV‐Vaccine Efficacy
  19. Comparison of HIV Type 1 Incidence Observed during Longitudinal Follow-Up with Incidence Estimated by Cross-Sectional Analysis Using the BED Capture Enzyme Immunoassay
  20. Temporal Trends in HIV Type 1 Incidence among Inner-City Childbearing Women in Atlanta: Use of the IgG-Capture BED-Enzyme Immunoassay
  21. Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries
  22. The Epidemiology of Simian Immunodeficiency Virus Infection in a Large Number of Wild- and Captive-Born Chimpanzees: Evidence for a Recent Introduction following Chimpanzee Divergence
  23. HIV transmission through health care in sub-Saharan Africa
  24. Performance of the OraQuick® and Hema-Strip® rapid HIV antibody detection assays by non-laboratorians
  25. Characterization of human immunodeficiency virus type-1 from HIV-1 seropositive cases with undetectable viremia
  26. Multiprotein HIV Type 1 Clade B DNA/MVA Vaccine: Construction, Safety, and Immunogenicity in Macaques
  27. Unsafe injections and transmission of HIV-1 in sub-Saharan Africa
  28. Two Percent of HIV-Positive U.S. Blood Donors Are Infected with Non-subtype B Strains
  29. HIV Type 1 Incidence Estimates by Detection of Recent Infection from a Cross-Sectional Sampling of Injection Drug Users in Bangkok: Use of the IgG Capture BED Enzyme Immunoassay
  30. Human Immunodeficiency Virus (HIV) Seropositivity among Uninfected HIV Vaccine Recipients
  31. Peripheral Blood Cell-Specific Cytokines in Persons with Untreated HIV Infection in Malawi, Africa
  32. HIV Seroincidence Among Patients at Clinics for Sexually Transmitted Diseases in Nine Cities in the United States
  33. HIV Seroincidence Among Patients at Clinics for Sexually Transmitted Diseases in Nine Cities in the United States
  34. Quantitative Detection of Increasing HIV Type 1 Antibodies after Seroconversion: A Simple Assay for Detecting Recent HIV Infection and Estimating Incidence
  35. Short Communication: Lack of Evidence for Infection with Simian Immunodeficiency Virus in Bonobos
  36. HIV-Specific IgG in Cervicovaginal Secretions of Exposed HIV-Uninfected Female Sexual Partners of HIV-Infected Men
  37. Chronic immune stimulation accelerates SIV‐induced disease progression
  38. Viral load differences in early infection with two HIV-1 subtypes
  39. HIV Seroconversion During Pregnancy and Risk for Mother-to-Infant Transmission
  40. HIV Seroconversion During Pregnancy and Risk for Mother-to-Infant Transmission
  41. Evaluation of a Sensitive/Less-Sensitive Testing Algorithm Using the 3A11-LS Assay for Detecting Recent HIV Seroconversion among Individuals with HIV-1 Subtype B or E Infection in Thailand
  42. Assessment of Antibody Assays for Identifying and Distinguishing Recent from Long-Term HIV Type 1 Infection
  43. Induction of Long-Term Protective Effects against Heterologous Challenge in SIVhu-Infected Macaques
  44. Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 ×106 cells/l
  45. Maternal Virus Load and Perinatal Human Immunodeficiency Virus Type 1 Subtype E Transmission, Thailand
  46. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand
  47. Impact of HIV Type 1 Subtype Variation on Viral RNA Quantitation
  48. Mucosal disruption due to use of a widely-distributed commercial vaginal product
  49. Presence of HTLV-I and HTLV-II Infection in Honduras
  50. Immune stimulation may contribute to enhanced progression of SIV induced disease in rhesus macaques
  51. Presentation of HIV V3 loop epitopes for enhanced antigenicity, immunogenicity and diagnostic potential
  52. Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina
  53. Infection of a Laboratory Worker with Simian Immunodeficiency Virus
  54. Teratogenic Effects of Neonatal Arenavirus Infection on the Developing Rat Cerebellum Are Abrogated by Passive Immunotherapy
  55. Human immunodeficiency virus 1-specific IgA capture enzyme immunoassay for early diagnosis of human immunodeficiency virus 1 infection in infants
  56. HIV‐1 Specific IgG Capture Enzyme Immunoassay to Study the Dynamics of HIV‐1 Antibody and to Diagnose HIV‐1 Infection in Infants
  57. Dynamics of Maternal IgG Antibody Decay and HIV-Specific Antibody Synthesis in Infants Born to Seropositive Mothers
  58. Highly specific V3 peptide enzyme immunoassay for seretyping HIV-1 specimens from Thailand
  59. Evaluation of Testing Algorithms Following the Use of Combination HIV-l/HIV-2 EIA for Screening Purposes
  60. Factors influencing HIV-1 banding patterns in miniaturized Western blot testing of dried blood spot specimens
  61. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission
  62. Oligomeric nature of transmembrane glycoproteins of HIV-2
  63. Equine infectious anemia virus, a putative lentivirus, contains polypeptides analogous to prototype-C oncornaviruses